Stockscreener 앱 받기
5.06
0.59%
-0.03
시간 외 거래:
5.06
전일 마감가:
$5.09
열려 있는:
$5
하루 거래량:
41,720
Relative Volume:
0.01
시가총액:
$40.99M
수익:
$5.66M
순이익/손실:
$-15.88M
주가수익비율:
-0.4473
EPS:
-11.3134
순현금흐름:
$-10.93M
1주 성능:
+1,165%
1개월 성능:
+642.26%
6개월 성능:
+377.36%
1년 성능:
-31.99%
1일 변동 폭
$4.96
$5.13
1주일 범위
$0.3651
$6.35
52주 변동 폭
$0.3252
$13.50
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, NTRA, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
5.06 | 3.24M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
Price to earnings forward of bioAffinity Technologies, Inc. – BOATS:BIAFW - TradingView
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - BioSpace
bioAffinity Technologies Implements Reverse Stock Split for Nasdaq - TipRanks
bioAffinity Technologies Sets 1-for-15 Reverse Stock Split for August 24 - citybiz
bioAffinity Technologies executes 1-for-15 reverse stock split - Investing.com
BioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - marketscreener.com
bioAffinity (BIAF) Earnings Snapshot: The Available Earnings Metric Delivers a Miss in the Reported Period; Trading Move: The Stock Ends Down 13.59% in Latest TradingFinancial Summary - vinanet.vn
These stocks are the most active in today's session - ChartMill
bioAffinity Technologies Signs Nationwide Federal Healthcare Distribution Agreement for CyPath Lung - Yahoo Finance
bioAffinity partners with AvMEDICAL for VA distribution - Investing.com
Form 8K bioAffinity Technologies Inc For: 18 August By Investing.com - Investing.com Nigeria
bioAffinity Technologies expands CyPath Lung federal distribution - TipRanks
bioAffinity Technologies inks federal distribution deal with AvMEDICAL to expand CyPath Lung access - TradingView
bioAffinity partners with AvMEDICAL for VA distribution By Investing.com - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
Enterprise value to revenue forward of bioAffinity Technologies, Inc. – NASDAQ:BIAF - TradingView
BioAffinity Technologies Closes $4 Million Private Placement - Moomoo
bioAffinity Technologies Warrant (BIAFW) Holds Steady at $0.06 as Trading Range ConvergesInsider Selling Alerts - vinanet.vn
bioAffinity Technologies closes $4M private placement - Investing.com
bioAffinity Technologies closes $4 million private placement of pre-funded warrants priced at $0.47 - Bitget
WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - PR Newswire
bioAffinity Technologies closes $4M private placement By Investing.com - Investing.com Australia
BioAffinity Technologies Announces Closing of - Moomoo
BioAffinity Technologies, Inc. announced that it has received $3.940766 million in funding - marketscreener.com
bioAffinity Technologies prices $4M private placement offering By Investing.com - Investing.com Nigeria
bioAffinity Technologies prices $4M private placement offering - Investing.com
WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - Barchart.com
bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules - Business Wire
BioAffinity Technologies, Inc. announced that it expects to receive $3.940766 million in funding - marketscreener.com
bioAffinity Technologies to Add Mexican Patent to its CyPath Lung Technology IP - Medical Product Outsourcing
bioAffinity Technologies Inc (BIAF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to EBITDA forward of bioAffinity Technologies, Inc. – NASDAQ:BIAFW - TradingView
Form 8K bioAffinity Technologies Inc For: 7 August By Investing.com - Investing.com Nigeria
bioAffinity Technologies earnings beat by $1.46, revenue fell short of estimates - Investing.com Canada
BioAffinity Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
bioAffinity Technologies, Inc. Q2 2026: Revenue $1.51M, EPS $(0.64) — 10-Q Summary - TradingView
BIAF: Strong CyPath® Lung growth drives Q2 2026, but liquidity concerns persist amid ongoing losses - TradingView
Price to sales forward of bioAffinity Technologies, Inc. – NASDAQ:BIAFW - TradingView
BIAF: Q2 2026 saw 216% CyPath Lung test growth and 19% revenue increase, with improved net loss - TradingView
bioAffinity Technologies reports Q2 2026 revenue $1.51M, net loss $3.37M, cash $2.43M - TradingView
Price to earnings forward of bioAffinity Technologies, Inc. – NASDAQ:BIAFW - TradingView
Press Release: BioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung - Moomoo
bioAffinity Technologies Inc (BIAF) Stock News Today - TradingKey
BIAF Q3 2025 Earnings: Loss of $4.74 Per Share Misses Estimates by 72%Estimate Dispersion - vinanet.vn
bioAffinity Technologies (BIAF) Holds Steady at $0.53 as Shares Consolidate Between Key Support and ResistanceMomentum Trade - vinanet.vn
bioAffinity Technologies (BIAF) Slips 6.24% to $0.56 as Selling Pressure IntensifiesVolume Breadth - vinanet.vn
bioAffinity Technologies Faces Nasdaq Delisting Risk After Notice - The Globe and Mail
bioAffinity Technologies, Inc. Revenue Breakdown – NASDAQ:BIAF - TradingView
Price to earnings forward of bioAffinity Technologies, Inc. – NASDAQ:BIAF - TradingView
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
1.51%
자본화:
|
볼륨(24시간):